Skip to main content

Table 3 Meta-analysis of the association between the XRCC1 Arg194Trp and Arg399Gln genetic polymorphisms and the risk of bladder cancer

From: Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk

Polymorphism

Stratification factor

Sample size

Number of studies

Test of association

  

Test of heterogeneity

Case

Control

OR (95% CI)

P-value

z

Model

I2(%)

P-value

Arg194Trp

Overall

4,751

6,102

14

1.69 (1.25-2.28)

0.001

3.39

F

35.9

0.112

 

Study in HWE

4,301

5,659

12

2.07 (1.36-3.15)

0.001

3.38

F

0.0

0.575

 

Ethnicity

         
 

Asian

1,051

1,101

5

1.97 (1.04-3.74)

0.038

2.08

R

64.1

0.025

 

Caucasian

3,700

5,001

9

1.44 (0.75-2.74)

0.270

1.10

F

0.0

0.538

 

Study quality

         
 

High

3,956

5,111

8

2.08 (1.36-3.18)

0.001

3.36

F

0

0.458

 

Low

795

991

6

1.35 (0.88-2.08)

0.352

0.93

R

71.6

0.030

Arg399Gln

Overall

5,654

7,136

18

1.10 (1.03-1.19)

0.008

2.67

F

0.0

0.596

 

Study in HWE

4,632

5,641

16

1.08 (1.00-1.18)

0.053

1.94

F

0.0

0.858

 

Ethnicity

         
 

Asian

1,364

1,438

6

1.14 (0.98-1.33)

0.082

1.74

F

0.0

0.562

 

Caucasian

4,290

5,698

12

1.09 (1.01-1.19)

0.037

2.09

F

0.0

0.460

 

Study quality

         
 

High

4,407

5,675

10

1.10 (1.01-1.19)

0.028

2.20

F

0.0

0.819

 

Low

1,247

1,461

8

1.13 (0.97-1.33)

0.122

1.55

R

28.1

0.204

  1. CI, confidence interval; F, fixed-effect model; HWE, Hardy–Weinberg equilibrium; OR, odds ratio; R, random-effect model.